Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Obesity is a risk factor for the development of type 2 diabetes and cardiovascular disease. However, it is now recognized that a subset of individuals have reduced cardiometabolic risk despite being obese. Paradoxically, a subset of lean individuals is reported to have high risk for cardiometabolic complications. These distinct subgroups of individuals are referred to as metabolically unhealthy normal weight (MUNW) and metabolically healthy obese (MHO). Although the clinical relevance of these subgroups remains debated, evidence shows a critical role for white adipose tissue (WAT) function in the development of these phenotypes. The goal of this review is to provide an overview of our current state of knowledge regarding the molecular and metabolic characteristics of WAT associated with MUNW and MHO. In particular, we discuss the link between different WAT depots, immune cell infiltration, and adipokine production with MUNW and MHO. Furthermore, we also highlight recent molecular insights made with genomic technologies showing that processes such as oxidative phosphorylation, branched‐chain amino acid catabolism, and fatty acid β‐oxidation differ between these phenotypes. This review provides evidence that WAT function is closely linked with cardiometabolic risk independent of obesity and thus contributes to the development of MUNW and MHO.—Badoud, F., Perreault, M., Zulyniak, M. A., Mutch, D. M., Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 29, 748–758 (2015). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · cited 1×
“Location of fat accumulationhas also been postulated as 1 explanation for the reduced cardiometabolic risk of MHO individuals despite their increasedbodyweight (37).”
BackgroundWhat we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · cited 12×
“This result aligns with that of Zhao et al., who showed that circulating Th22 cells were positively correlated with insulin resistance and T2D (72).”
BackgroundInfluentialMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
Bastien, M., Poirier, P., Lemieux, I., & Després, J.-P. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.016 · Cited by 1,125
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893 · cited 2×
“For this reason, uric acid has been proposed as a potential biomarker for MUNW (8).”
BackgroundMetabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals
Blüher, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346ccc · Cited by 632
Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607
The metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500 · cited 1×
“(52),who showed that insulin-resistant individuals were characterized by high circulating levels of both fetuin-A and free fatty acids, thereby identifying a potential new molecular player linking lipids and inflammation.”
BackgroundBrochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A. H., & Poehlman, E. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7365 · Cited by 443 · cited 4×
“Others have reached the same conclusion, suggesting that the preserved metabolic function of MHO individuals may be attributed to reduced amounts of VAT (21, 38).”
BackgroundInfluentialPlasma fetuin-A levels and the risk of type 2 diabetes
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Häring, H.-U., & Schulze, M. B. (2008) · Diabetes · doi:10.2337/db08-0538 · Cited by 379
McLaughlin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., Reaven, G. M., & Cushman, S. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0708-y · Cited by 364
Dvorak, R. V., DeNino, W. F., Ades, P. A., & Poehlman, E. T. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2210 · Cited by 243 · cited 1×
“(36), who reported increased body fat percentage, as well as higher SAT and VAT abdominal adiposity, in MUNW women compared with LH women.”
BackgroundMetabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0265 · Cited by 215 · cited 1×
“30 kg/m(2)), with elevated triglycerides (TG) andLDL cholesterol (LDL-c) levels and reduced HDL cholesterol (HDL-c) compared with LH individuals (2, 5, 10).”
BackgroundThe relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity
O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009997 · Cited by 211 · cited 1×
“In contrast, MHO individuals appear to have smaller adipocytes (;15%smaller) than theirMUOcounterparts (18, 43, 44).”
BackgroundCirculating fetuin-A and free fatty acids interact to predict insulin resistance in humans
Stefan, N., & Häring, H.-U. (2013) · Nature Medicine · doi:10.1038/nm.3116 · Cited by 160 · cited 1×
“For example, fetuin-A is a hepatokine that inhibits insulin signaling and induces proinflammatory cytokine expression inWAT by facilitating the activation of Toll-like receptors by saturated fatty acids (49, 50).”
BackgroundLackey, D. E., Burk, D. H., Ali, M. R., Mostaedi, R., Smith, W. H., Park, J., Scherer, P. E., Seay, S. A., McCoin, C. S., Bonaldo, P., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00476.2013 · Cited by 111
Cited by
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 335
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese
Xia, M.-F., Chen, Y., Lin, H.-D., Ma, H., Li, X.-M., Aleteng, Q., Li, Q., Wang, D., Hu, Y., Pan, B.-S., et al. (2016) · Scientific Reports · doi:10.1038/srep38214 · Cited by 292
Differential DNA Methylation in Relation to Age and Health Risks of Obesity
Mansego, M., Milagro, F., Zulet, M., Moreno-Aliaga, M., & Martínez, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160816816 · Cited by 47
“The relatively low risk of cardiovascular disease among metabolically healthy people with respect to unhealthy obese people has been attributed to differences in white adipose tissue function between both groups of patients [24].”
BackgroundKim, J., Choi, A., & Kwon, Y. H. (2020) · Nutrients · doi:10.3390/nu12041103 · Cited by 18
“Here, we observed significantly lower inflammation and insulin resistance in the LP/HF group compared to the C/HF group in spite of increases in epididymal adipose fat mass and adiposity, which are similar to the phenotype of metabolically healthy obese (MHO) individuals [40].”
Result
Metadata
- Authors
- Badoud, F., Perreault, M., Zulyniak, M. A., & Mutch, D. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2014-11-19
- Volume
- 29
- Issue
- 3
- Pages
- 748-758
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2147208509
- Cited by
- 127
- References
- 23
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.